Giulio Caravagna

28PUBLICATIONS
219CO-AUTHORS
Predictive and prognostic markersCancer geneticsGene expression (incl. microarray and other genome-wide approaches)Microelectromechanical systems (MEMS)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 31, 2026
Gene mutant dosage is associated with prognosis and metastatic tropism in 60,000 clinical cancer samples.

|Jul 15, 2026
Dissecting cancer in a non-mammalian model: genomic insights from lemon frost geckos.

|Jul 14, 2026
Clinical significance of EGFR amplification in patients with EGFR-mutated metastatic non-small cell lung cancer receiving first-line osimertinib.

|Jun 19, 2026
Scalable, fast and accurate differential gene expression testing from millions of cells of multiple patients.

|May 25, 2026
Gene mutant dosage is associated with prognosis and metastatic tropism in 60,000 clinical cancer samples.

|Mar 27, 2026
Extending differential gene expression testing to handle genome aneuploidy in cancer.

Katsiaryna Davydzenka, Giulio Caravagna, Guido Sanguinetti

Pageof 5

Frequent Collaborators

11 joint publications

Trevor A Graham

10 joint publications

Andrea Sottoriva

8 joint publications

Salvatore Milite

4 joint publications

Eszter Lakatos